Literature DB >> 10438361

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

D van Soolingen1, M W Borgdorff, P E de Haas, M M Sebek, J Veen, M Dessens, K Kremer, J D van Embden.   

Abstract

To disclose risk factors for active tuberculosis transmission in the Netherlands, restriction fragment length polymorphism (RFLP) patterns of 78% of the Mycobacterium tuberculosis isolates, from the period 1993-1997, were analyzed. Of the respective 4266 cases, 46% were found in clusters of isolates with identical RFLPs, and 35% were attributed to active transmission. The clustering percentage increased strongly with the number of isolates; taking this into account, fewer cases were clustered than has been reported in other studies. Contact investigations in the five largest clusters of 23-47 patients suggested epidemiological linkage between cases. Of patients identified through contact tracing, 91% were clustered. Demographic risk factors for active transmission of tuberculosis included male sex, urban residence, Dutch and Surinamese nationality, and long-term residence in the Netherlands. Human immunodeficiency virus infection was not an independent risk factor for active transmission. Isoniazid-resistant strains were relatively less frequently clustered, suggesting that these generated fewer secondary cases.

Entities:  

Mesh:

Year:  1999        PMID: 10438361     DOI: 10.1086/314930

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  108 in total

1.  Criteria for the control of drug-resistant tuberculosis.

Authors:  C Dye; B G Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Discrimination of single-copy IS6110 DNA fingerprints of Mycobacterium tuberculosis isolates by high-resolution minisatellite-based typing.

Authors:  Ann S G Lee; Lynn L H Tang; Irene H K Lim; Richard Bellamy; Sin-Yew Wong
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

3.  Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV-tuberculosis coinfected populations.

Authors:  Ted Cohen; Marc Lipsitch; Rochelle P Walensky; Megan Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

4.  Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Authors:  Thomas C Victor; Petra E W de Haas; Annemarie M Jordaan; Gian D van der Spuy; Madalene Richardson; D van Soolingen; Paul D van Helden; Robin Warren
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 5.  The transmission of tuberculosis in the light of new molecular biological approaches.

Authors:  A Seidler; A Nienhaus; R Diel
Journal:  Occup Environ Med       Date:  2004-02       Impact factor: 4.402

6.  Will tuberculosis become resistant to all antibiotics?

Authors:  C Dye; M A Espinal
Journal:  Proc Biol Sci       Date:  2001-01-07       Impact factor: 5.349

7.  Molecular epidemiology of Mycobacterium tuberculosis in western Sweden.

Authors:  Karine Brudey; Max Gordon; Peter Moström; Liselott Svensson; Bodil Jonsson; Christophe Sola; Malin Ridell; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.

Authors:  Halima M Said; Marleen M Kock; Nazir A Ismail; Matsie Mphahlele; Kamaldeen Baba; Shaheed V Omar; Ayman G Osman; Anwar A Hoosen; Marthie M Ehlers
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

9.  Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  E M Streicher; S L Sampson; K Dheda; T Dolby; J A Simpson; T C Victor; N C Gey van Pittius; P D van Helden; R M Warren
Journal:  J Clin Microbiol       Date:  2015-09-02       Impact factor: 5.948

Review 10.  Tuberculosis: drug resistance, fitness, and strategies for global control.

Authors:  Erik C Böttger; Burkhard Springer
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.